Revisiting the Animal Drug Compounding Debate

September 15, 2016 9:15am

Theodore M. Sullivan
Partner
Quarles & Brady LLP (Washington, DC)

Rachael G. Pontikes
Partner
Duane Morris LLP (Chicago, IL)

Moderator:

Brian J. Malkin
Senior Counsel
McGuireWoods LLP

The animal drug compounding controversy continues. While, FDA issued a draft guidance on the matter last year. There still is no specific Federal law or Amendment to the Food Drug and Cosmetic Act regulating the practice. In this federal vacuum, various states are now chiming in with their own proposed legislation. In this session, our panelists will continue the discussion from last year and revisit the pros and cons of compounding as well as new compounding controversies. Points of discussion will include:

  • Status of the FDA draft guidance on animal drug compounding
  • Review of various state laws attempting to regulate animal drug compounding
  • Use of controlled substances in animal drug compounding
  • Veterinarian input in the animal drug compounding controversy